High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.0M
$4,025,821
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
BBIO
S
BridgeBio Pharma, Inc.
Valantine Hannah
• Director
10b5-1 SellΔOwn -53.7%
2026-03-10
$624,312
|
||||||
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 SellΔOwn -53.7%
|
2026-03-10 | $624,312 | S | Form 4 |
|
BBIO
S
BridgeBio Pharma, Inc.
Valantine Hannah
• Director
10b5-1 SellΔOwn -44.3%
2026-02-27
$1,717,781Largex2
|
||||||
| BBIO |
BridgeBio Pharma, Inc.
|
Director
10b5-1 SellΔOwn -44.3%
|
2026-02-27 | $1,717,781Largex2 | S | Form 4 |
|
BBIO
S
BridgeBio Pharma, Inc.
Valantine Hannah
• Director
Discretionary SellΔOwn -77.3%
2025-11-12
$1,683,728Large
|
||||||
| BBIO |
BridgeBio Pharma, Inc.
|
Director
Discretionary SellΔOwn -77.3%
|
2025-11-12 | $1,683,728Large | S | Form 4 |